MTSI enters the back half of June with its first meaningful pullback since the May earnings blowout — and a fresh analyst upgrade arriving almost exactly as the stock gives ground.
The session decline tells the sharpest part of the story. MTSI fell 6.1% on June 23 to close at $372.15, reversing most of the week's 1% gain in a single day. The drop puts the stock roughly 6.5% below its recent highs and back below the prior analyst consensus target of $398. That target has now been superseded: Stifel raised its price objective to $450 on June 24, maintaining its Buy rating — the most recent and most bullish move on the Street. The gap between the current price and that new target is now nearly 21%.
The Street as a whole has been moving in one direction since the May 7 print. Following that earnings blowout — which produced a 16% single-day gain and a 24% five-day move — most covering analysts lifted targets aggressively. Barclays raised to $450 (Overweight). Evercore ISI moved to $427 (Outperform). Needham went to $400 (Buy). Even more cautious voices upgraded their numbers: JP Morgan lifted to $345 (Neutral) and Susquehanna to $350 (Neutral). The consensus mean of $398 is now lagging several of those individual targets, suggesting the distribution is skewing more bullish than the average implies. Bulls point to a multi-year growth cycle in optical and RF solutions across data center, telecom, and defense; bears flag the valuation — a trailing P/E above 66 and EV/EBITDA near 61 — and the risk of acquisition missteps in a competitive semiconductor market.
Options positioning has eased from the defensive peak flagged in the previous note but has not fully normalized. The put/call ratio dropped to 0.44, back close to its 20-day average of 0.42 and only a fraction of a standard deviation above it. A month ago the PCR was running near 0.18; by mid-June it had climbed to nearly 0.59 before pulling back this week. The direction is encouraging for bulls, but the ratio has not returned to the low levels that characterized the stock's strongest advance. Borrow conditions remain entirely benign — availability is at 2,723%, meaning shares to borrow vastly outnumber those already shorted. Short interest is only 2.8% of the free float, ticked up 9.4% on the week but remains well within the low range. Cost to borrow eased slightly to 0.47%. None of this points to short-side pressure as a meaningful driver of the day's decline.
Institutional ownership tells a quietly constructive story. FMR added 4.1 million shares in the most recent filing period, lifting its stake to 13.9% of the company. BlackRock added 1 million shares to reach 11.2%. Wellington Management added over 530,000 shares. Against that backdrop, CEO Stephen Daly sold just under $3.4 million across multiple tranches on May 29 — at prices between $360 and $381 — all scored at low significance. The 90-day net insider figure is a positive $7.2 million across 19,723 net shares, so the picture at the institutional and insider level is broadly supportive even with the CEO trimming.
The next scheduled catalyst is the August 6 earnings release. With the stock now sitting 21% below Stifel's freshly raised target and the prior print having produced outsized moves in both the day-one and five-day windows, the question heading into that date is whether the current $372 level represents a reset of expectations or simply a pause in the post-May advance.
See the live data behind this article on ORTEX.
Open MTSI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
